Modified annexin proteins and methods for their use in organ transplantation

Details for Australian Patent Application No. 2006327095 (hide)

Owner Alavita Pharmaceuticals, Inc.

Inventors Allison, Anthony

Agent Davies Collison Cave

Pub. Number AU-A-2006327095

PCT Pub. Number WO2007/073509

Priority 11/267,837 03.11.05 US

Filing date 25 October 2006

Wipo publication date 28 June 2007

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

22 May 2008 PCT application entered the National Phase

  PCT publication WO2007/073509 Priority application(s): WO2007/073509

9 October 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 09 Jul 2008 2006327239 BJ Services Company, U.S.A. The nature of the amendment is: Delete priority details PCT/US2005/047007 US 22 Dec 2005

24 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006327105-Compounds and methods for thiolcontaining compound efflux and cancer treatment

2006327094-Method and system for adaptive encoding of real-time information in wireless networks